Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
Clinical trial NCT03689894 · TERMINATED
Trial details
- NCT number
- NCT03689894
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2021-09-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.